Thalia S Field1, Lesly A Pearce2, Richard W Asinger3, Nathan G Chan Smyth4, Sabe K De5, Robert G Hart6, Oscar R Benavente4. 1. Division of Neurology, Center for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: thalia.field@ubc.ca. 2. Biostatistical consultant, Minot, North Dakota. 3. Department of Medicine, Hennepin Heart Center, University of Minnesota, Minneapolis, Minnesota. 4. Division of Neurology, Center for Brain Health, University of British Columbia, Vancouver, British Columbia, Canada. 5. Division of Cardiology, Dalhousie University, Halifax, Nova Scotia, Canada. 6. Division of Neurology, Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada.
Abstract
BACKGROUND: The spectrum, prevalence, and prognostic implications of abnormal left ventricular geometry (LVG) in patients with lacunar stroke are unknown. We examined the spectrum of LVG and its relationship with vascular risk factors and outcomes after lacunar stroke. METHODS:LVG was determined with transthoracic echocardiography for 1961 patients with magnetic resonance imaging-verified recent lacunar stroke participating in the Secondary Prevention of Small Subcortical Strokes trial. Multivariable logistic regression and Cox proportional hazards models were used to identify characteristics independently associated with LVG and to estimate risk from abnormal LVG for recurrent stroke and death. RESULTS:Abnormal LVG was present in 77%. Hispanic (odds ratio [OR], 1.4; 95% confidence interval, 1.1-1.8) or black (OR, 2.0; 1.3-2.9) race-ethnicity, diabetes (OR, 1.3; 1.0-1.7), hypertension, impaired renal function (OR, 1.8; 1.2-2.5), intracranial stenosis (OR, 1.5; 1.1-2.1), and abnormal left ventricular function (OR, 2.0; 1.4-3.0) were independently associated with abnormal LVG. Subjects with abnormal LVG also more frequently had advanced manifestations of small-vessel disease specifically previous subcortical infarcts and white matter hyperintensities. After adjusting for assigned treatments, clinical risk factors, and advanced manifestations of small-vessel disease, subjects with abnormal LVG remained at increased risk of stroke recurrence (hazard ratio, 1.5; confidence interval, 1.0-2.4). There was no interaction between LVG and assigned antiplatelet or blood pressure target. Abnormal LVG was not associated with mortality. CONCLUSIONS:LVG consistent with chronic hypertensive changes was highly prevalent and correlated with neuroradiologic manifestations of small-vessel disease in lacunar stroke patients. These results support the constructs that both cerebral small-vessel disease and LVG represent end-organ consequences of chronic hypertension.
RCT Entities:
BACKGROUND: The spectrum, prevalence, and prognostic implications of abnormal left ventricular geometry (LVG) in patients with lacunar stroke are unknown. We examined the spectrum of LVG and its relationship with vascular risk factors and outcomes after lacunar stroke. METHODS: LVG was determined with transthoracic echocardiography for 1961 patients with magnetic resonance imaging-verified recent lacunar stroke participating in the Secondary Prevention of Small Subcortical Strokes trial. Multivariable logistic regression and Cox proportional hazards models were used to identify characteristics independently associated with LVG and to estimate risk from abnormal LVG for recurrent stroke and death. RESULTS: Abnormal LVG was present in 77%. Hispanic (odds ratio [OR], 1.4; 95% confidence interval, 1.1-1.8) or black (OR, 2.0; 1.3-2.9) race-ethnicity, diabetes (OR, 1.3; 1.0-1.7), hypertension, impaired renal function (OR, 1.8; 1.2-2.5), intracranial stenosis (OR, 1.5; 1.1-2.1), and abnormal left ventricular function (OR, 2.0; 1.4-3.0) were independently associated with abnormal LVG. Subjects with abnormal LVG also more frequently had advanced manifestations of small-vessel disease specifically previous subcortical infarcts and white matter hyperintensities. After adjusting for assigned treatments, clinical risk factors, and advanced manifestations of small-vessel disease, subjects with abnormal LVG remained at increased risk of stroke recurrence (hazard ratio, 1.5; confidence interval, 1.0-2.4). There was no interaction between LVG and assigned antiplatelet or blood pressure target. Abnormal LVG was not associated with mortality. CONCLUSIONS: LVG consistent with chronic hypertensive changes was highly prevalent and correlated with neuroradiologic manifestations of small-vessel disease in lacunar strokepatients. These results support the constructs that both cerebral small-vessel disease and LVG represent end-organ consequences of chronic hypertension.
Authors: Melvin D Cheitlin; William F Armstrong; Gerard P Aurigemma; George A Beller; Fredrick Z Bierman; Jack L Davis; Pamela S Douglas; David P Faxon; Linda D Gillam; Thomas R Kimball; William G Kussmaul; Alan S Pearlman; John T Philbrick; Harry Rakowski; Daniel M Thys; Elliott M Antman; Sidney C Smith; Joseph S Alpert; Gabriel Gregoratos; Jeffrey L Anderson; Loren F Hiratzka; Sharon Ann Hunt; Valentin Fuster; Alice K Jacobs; Raymond J Gibbons; Richard O Russell Journal: Circulation Date: 2003-09-02 Impact factor: 29.690
Authors: Oscar R Benavente; Carole L White; Lesly Pearce; Pablo Pergola; Ana Roldan; Marie-France Benavente; Christopher Coffey; Leslie A McClure; Jeff M Szychowski; Robin Conwit; Patricia A Heberling; George Howard; Carlos Bazan; Gabriela Vidal-Pergola; Robert Talbert; Robert G Hart Journal: Int J Stroke Date: 2011-01-26 Impact factor: 5.266
Authors: Oscar R Benavente; Robert G Hart; Leslie A McClure; Jeffrey M Szychowski; Christopher S Coffey; Lesly A Pearce Journal: N Engl J Med Date: 2012-08-30 Impact factor: 91.245
Authors: Carole L White; Jeff M Szychowski; Ana Roldan; Marie-France Benavente; Edwin J Pretell; Oscar H Del Brutto; Carlos S Kase; Antonio Arauz; Brett C Meyer; Irene Meissner; Bart M Demaerschalk; Leslie A McClure; Christopher S Coffey; Lesly A Pearce; Robin Conwit; Lisa H Irby; Kalyani Peri; Pablo E Pergola; Robert G Hart; Oscar R Benavente Journal: J Stroke Cerebrovasc Dis Date: 2012-04-17 Impact factor: 2.136
Authors: Richard B Devereux; Vittorio Palmieri; Jennifer E Liu; Kristian Wachtell; Jonathan N Bella; Kurt Boman; Eva Gerdts; Markku S Nieminen; Vasilios Papademetriou; Björn Dahlöf Journal: J Hypertens Date: 2002-07 Impact factor: 4.844
Authors: David A Bluemke; Richard A Kronmal; João A C Lima; Kiang Liu; Jean Olson; Gregory L Burke; Aaron R Folsom Journal: J Am Coll Cardiol Date: 2008-12-16 Impact factor: 24.094
Authors: Eva Gerdts; Dana Cramariuc; Giovanni de Simone; Kristian Wachtell; Björn Dahlöf; Richard B Devereux Journal: Eur J Echocardiogr Date: 2008-05-13
Authors: Andrew S Levey; Lesley A Stevens; Christopher H Schmid; Yaping Lucy Zhang; Alejandro F Castro; Harold I Feldman; John W Kusek; Paul Eggers; Frederick Van Lente; Tom Greene; Josef Coresh Journal: Ann Intern Med Date: 2009-05-05 Impact factor: 25.391
Authors: Abiodun M Adeoye; Bruce Ovbiagele; Joshua O Akinyemi; Okechukwu S Ogah; Rufus Akinyemi; Mulugeta Gebregziabher; Kolawole Wahab; Adekunle G Fakunle; Adeseye Akintunde; Oladimeji Adebayo; Akinyemi Aje; Hemant K Tiwari; Donna Arnett; Francis Agyekum; Lambert T Appiah; Ganiyu Amusa; Taiwo O Olunuga; Akpa Onoja; Fred S Sarfo; Albert Akpalu; Carolyn Jenkins; Daniel Lackland; Lukman Owolabi; Morenikeji Komolafe; Moyinoluwalogo M Faniyan; Oyedunni Arulogun; Reginald Obiako; Mayowa Owolabi Journal: J Am Heart Assoc Date: 2019-05-30 Impact factor: 5.501